Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-09-12
1992-08-25
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514311, 514319, C07D21514, C07D21324, C07D40312
Patent
active
051419475
ABSTRACT:
Disclosed herein is a fibrinolysis-enhancing agent comprising, as an effective ingredient, an N.sup.2 -arylsulfonyl-L-arginine amide represented by the general formula (I): ##STR1## wherein R.sup.1 is a group of the formula: ##STR2## where R.sup.3 is an alkyl group having 3 to 5 carbon atoms or an alkoxyalkyl group having 2 to 4 carbon atoms and R.sup.4 is an alkyl group having 1 to 3 carbon atoms; and R.sup.2 is a group of the formula: ##STR3## where R.sup.5 and R.sup.6 are independently hydrogen atom, methyl group or methoxy group provided that they cannot be hydrogen atoms simultaneously, and R.sup.7 is an alkyl group having 1 to 3 carbon atoms; or a salt thereof. The agent is used in combination with a plasminogen activator.
REFERENCES:
patent: 3875005 (1975-04-01), Belloc et al.
patent: 3919414 (1975-11-01), Herrin et al.
patent: 4073916 (1978-02-01), Okamoto et al.
patent: 4258192 (1981-03-01), Okamoto et al.
patent: 4532129 (1985-07-01), Comi et al.
Kikumoto Ryoji
Tamao Yoshikuni
Mitsubishi Kasei Corporation
Springer David B.
LandOfFree
Fibrinolysis-enhancing agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinolysis-enhancing agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinolysis-enhancing agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385255